COMPANY
Cepheid
Hiring
| Title | Location (from posting) | Employer posted | First seen |
|---|---|---|---|
| Project Manager | Bangalore, Karnātaka, India | Oct 22, 2026 | Oct 22, 2026 |
| QA Validation Professional – P2 | Bangalore, Karnātaka, India | Oct 22, 2026 | Oct 22, 2026 |
| EHS Engineer | Sunnyvale, California, United States of America | Oct 22, 2026 | Oct 23, 2026 |
| Production Technician III | SE Bothell, Washington, United States of America | Oct 22, 2026 | Oct 23, 2026 |
| KI CHaSE 2026 - Your interest in future openings at Cepheid | Solna, Sweden | Oct 22, 2026 | Oct 23, 2026 |
Timeline
- FDA FDA 510(k) clearance: Xpert Respiratory Panel — K261336, Sep 25, 2026. Applicant at approval: Cepheid. source ↗
- FDA FDA 510(k) clearance: Xpert Hemorrhagic Fever — K261362, Aug 7, 2026. Applicant at approval: Cepheid. source ↗
- FDA FDA 510(k) clearance: Xpert Carba-R — K261867, Jul 2, 2026. Applicant at approval: Cepheid®. source ↗
- FDA FDA 510(k) clearance: Xpert Hemorrhagic Fever — K253653, Feb 20, 2026. Applicant at approval: Cepheid. source ↗
- FDA FDA 510(k) clearance: Xpert GI Panel — K251721, Jan 16, 2026. Applicant at approval: Cepheid. source ↗
- Trial start —: Xpert® Tropical Fever Test on GeneXpert® Edge X System source ↗
- Trial start —: Xpert® ERP on the GeneXpert® System source ↗
- FDA FDA 510(k) clearance: Xpert Xpress CoV-2/Flu/RSV plus — K250995, May 1, 2025. Applicant at approval: Cepheid®. source ↗
- FDA FDA 510(k) clearance: Xpert Xpress CoV-2/Flu/RSV plus — K250996, May 1, 2025. Applicant at approval: Cepheid®. source ↗
- FDA FDA 510(k) clearance: Xpert C. difficile/Epi — K243730, Feb 28, 2025. Applicant at approval: Cepheid®. source ↗
- FDA FDA 510(k) clearance: Xpert® FII & FV — K250218, Feb 21, 2025. Applicant at approval: Cepheid. source ↗
- FDA FDA 510(k) clearance: Xpert® Xpress CoV-2 plus (XPRS-COV2-10) — K242109, Jan 15, 2025. Applicant at approval: Cepheid®. source ↗
- Trial start —: Xpert® Hemorrhagic Fever on the GeneXpert® Edge X System source ↗
- FDA FDA 510(k) clearance: Xpert Xpress CoV-2/Flu/RSV plus — K242071, Jan 10, 2025. Applicant at approval: Cepheid. source ↗
- FDA FDA 510(k) clearance: Xpert MRSA/SA SSTI — K243625, Dec 18, 2024. Applicant at approval: Cepheid®. source ↗
- FDA FDA 510(k) clearance: Xpert vanA — K243405, Nov 21, 2024. Applicant at approval: Cepheid®. source ↗
- Partnership Partnership / licensing announced Nov 19, 2024. Source: company's own press page. source ↗
- FDA FDA 510(k) clearance: Xpert® SA Nasal Complete — K243070, Oct 25, 2024. Applicant at approval: Cepheid®. source ↗
- Trial start —: Xpert Hemorrhagic Fever on Edge X in Trained and Untrained Users source ↗
- Trial start —: Xpert Hepatitis-C Virus (HCV) Test on the GeneXpert Xpress System source ↗
- Trial start —: A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X) source ↗
- Trial start —: Clinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML) source ↗
- Trial start —: Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer source ↗
- Trial start —: Clinical Evaluation of the Xpert® HIV-1 VL source ↗
- Trial start —: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects source ↗
Funding
- Partnership / licensing announced Nov 19, 2024. Source: company's own press page. source ↗
Clinical trials (lead sponsor) 10
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07591740 | Xpert Hemorrhagic Fever on Edge X in Trained and Untrained Users | Not listed | Completed | Oct 21, 2024 | Mar 14, 2025 (actual) |
| NCT07520279 | Xpert® Tropical Fever Test on GeneXpert® Edge X System | Not listed | Enrolling by invitation | Aug 18, 2025 | Aug 31, 2026 (estimated) |
| NCT07489846 | Xpert® ERP on the GeneXpert® System | Not listed | Completed | May 13, 2025 | Jan 28, 2026 (actual) |
| NCT07370454 | Xpert® Hemorrhagic Fever on the GeneXpert® Edge X System | Not listed | Completed | Jan 13, 2025 | Apr 29, 2025 (actual) |
| NCT06508996 | Xpert Hepatitis-C Virus (HCV) Test on the GeneXpert Xpress System | Not listed | Completed | Feb 6, 2024 | May 10, 2024 (actual) |
| NCT03664258 | A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X) | Not listed | Completed | Jun 6, 2018 | Dec 31, 2021 (actual) |
| NCT03125460 | Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer | Not listed | Completed | 2016-12 | 2019-02 (actual) |
| NCT03421626 | Clinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML) | Not listed | Completed | Nov 8, 2017 | Aug 20, 2018 (actual) |
| NCT02461576 | Clinical Evaluation of the Xpert® HIV-1 VL | Not listed | Completed | 2015-07 | Feb 24, 2017 (actual) |
| NCT01587469 | Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects | Not listed | Completed | 2012-05 | Feb 21, 2014 (actual) |
FDA records (last 2 years)
- FDA 510(k) clearance: Xpert Respiratory Panel — K261336, Sep 25, 2026. Applicant at approval: Cepheid. source ↗
- FDA 510(k) clearance: Xpert Hemorrhagic Fever — K261362, Aug 7, 2026. Applicant at approval: Cepheid. source ↗
- FDA 510(k) clearance: Xpert Carba-R — K261867, Jul 2, 2026. Applicant at approval: Cepheid®. source ↗
- FDA 510(k) clearance: Xpert Hemorrhagic Fever — K253653, Feb 20, 2026. Applicant at approval: Cepheid. source ↗
- FDA 510(k) clearance: Xpert GI Panel — K251721, Jan 16, 2026. Applicant at approval: Cepheid. source ↗
- FDA 510(k) clearance: Xpert Xpress CoV-2/Flu/RSV plus — K250995, May 1, 2025. Applicant at approval: Cepheid®. source ↗
- FDA 510(k) clearance: Xpert Xpress CoV-2/Flu/RSV plus — K250996, May 1, 2025. Applicant at approval: Cepheid®. source ↗
- FDA 510(k) clearance: Xpert C. difficile/Epi — K243730, Feb 28, 2025. Applicant at approval: Cepheid®. source ↗
- FDA 510(k) clearance: Xpert® FII & FV — K250218, Feb 21, 2025. Applicant at approval: Cepheid. source ↗
- FDA 510(k) clearance: Xpert® Xpress CoV-2 plus (XPRS-COV2-10) — K242109, Jan 15, 2025. Applicant at approval: Cepheid®. source ↗
- FDA 510(k) clearance: Xpert Xpress CoV-2/Flu/RSV plus — K242071, Jan 10, 2025. Applicant at approval: Cepheid. source ↗
- FDA 510(k) clearance: Xpert MRSA/SA SSTI — K243625, Dec 18, 2024. Applicant at approval: Cepheid®. source ↗
- FDA 510(k) clearance: Xpert vanA — K243405, Nov 21, 2024. Applicant at approval: Cepheid®. source ↗
- FDA 510(k) clearance: Xpert® SA Nasal Complete — K243070, Oct 25, 2024. Applicant at approval: Cepheid®. source ↗
NIH awards 7
- NIH award 5R42AI052523-04 FY2008: $1,160,774 awarded for that fiscal year; activity R42 (STTR); PI ALLAND, DAVID; recipient as written: CEPHEID, SUNNYVALE, CA. Sample Processing Cartridges for Rapid PCR TB Detection source ↗
- NIH award 5R42AI052523-03 FY2007: $1,343,564 awarded for that fiscal year; activity R42 (STTR); PI ALLAND, DAVID; recipient as written: CEPHEID, SUNNYVALE, CA. Sample Processing Cartridges for Rapid PCR TB Detection source ↗
- NIH award 2R42AI052523-02 FY2006: $1,479,189 awarded for that fiscal year; activity R42 (STTR); PI ALLAND, DAVID; recipient as written: CEPHEID, SUNNYVALE, CA. Sample Processing Cartridges for Rapid PCR TB Detection source ↗
- NIH award 5R42CA099123-03 FY2005: $956,316 awarded for that fiscal year; activity R42 (STTR); PI KOZMA, LYNN MARIE; recipient as written: CEPHEID, SUNNYVALE, CA. Automated RNA Isolation and RT-PCR for Cancer Detectio source ↗
- NIH award 4R42CA099123-02 FY2004: $922,381 awarded for that fiscal year; activity R42 (STTR); PI CHING, JESUS; recipient as written: CEPHEID, SUNNYVALE, CA. Automated RNA Isolation and RT-PCR for Cancer Detection source ↗
- NIH award 1R42CA099123-01 FY2003: $142,585 awarded for that fiscal year; activity R42 (STTR); PI CHING, JESUS; recipient as written: CEPHEID, SUNNYVALE, CA. Automated RNA Isolation and RT-PCR for Cancer Detection source ↗
- NIH award 1R41AI052523-01 FY2002: $376,432 awarded for that fiscal year; activity R41 (STTR); PI ALLAND, DAVID; recipient as written: CEPHEID, SUNNYVALE, CA. Sample Processing Cartridges for Rapid PCR TB Detection source ↗
Open jobs 48
| Title | Location (from posting, not HQ) | Employer posted | First seen | Level |
|---|---|---|---|---|
| Project Manager | Bangalore, Karnātaka, India | Oct 22, 2026 | Oct 22, 2026 | Not stated |
| QA Validation Professional – P2 | Bangalore, Karnātaka, India | Oct 22, 2026 | Oct 22, 2026 | Not stated |
| EHS Engineer | Sunnyvale, California, United States of America | Oct 22, 2026 | Oct 23, 2026 | Not stated |
| Production Technician III | SE Bothell, Washington, United States of America | Oct 22, 2026 | Oct 23, 2026 | Not stated |
| KI CHaSE 2026 - Your interest in future openings at Cepheid | Solna, Sweden | Oct 22, 2026 | Oct 23, 2026 | Not stated |
| Field Service Engineer - Pune | Pune, Mahārāshtra, India | Oct 21, 2026 | Oct 21, 2026 | Not stated |
| Staff Electrical and Machine Safety Engineer | Newark, California, United States of America | Oct 21, 2026 | Oct 22, 2026 | Not stated |
| Sr. Manager, APAC Instrument Operations | Penang, Pulau Pinang (Penang), Malaysia | Oct 16, 2026 | Oct 16, 2026 | Not stated |
| Senior Financial Analyst | Sunnyvale, California, United States of America | Oct 16, 2026 | Oct 17, 2026 | Not stated |
| Product Management Director, Software | Sunnyvale, California, United States of America | Oct 16, 2026 | Oct 17, 2026 | Not stated |
| Field Application Engineer | Bilbao, Spain | Oct 14, 2026 | Oct 15, 2026 | Not stated |
| EHS Engineer | SE Bothell, Washington, United States of America | Oct 13, 2026 | Oct 15, 2026 | Not stated |
| Executive Assistant (Onsite: Sunnyvale, CA) | Sunnyvale, California, United States of America | Oct 13, 2026 | Oct 15, 2026 | Not stated |
| Senior Key Account Manager, Gauteng (Invitro Diagnostics) | Centurion, Gauteng, South Africa | Oct 12, 2026 | Oct 12, 2026 | Not stated |
| Senior Field Actions Specialist | Sunnyvale, California, United States of America | Oct 10, 2026 | Oct 12, 2026 | Not stated |
| Field Application Engineer | SEVILLA, Spain | Oct 9, 2026 | Oct 12, 2026 | Not stated |
| Senior Supplier Quality Engineer | Penang, Selangor, Malaysia | Oct 9, 2026 | Oct 12, 2026 | Not stated |
| Lead Electrical Engineer II | Bangalore, Karnātaka, India | Oct 6, 2026 | Oct 12, 2026 | Not stated |
| Lead Biostatistician | Bangalore, Karnātaka, India | Oct 6, 2026 | Oct 12, 2026 | Not stated |
| Territory Sales Executive/Responsable des Ventes Territoriales | Montreal, Quebec, Canada | Oct 2, 2026 | Oct 12, 2026 | Not stated |
| Director, Global Trade Compliance | New York, United States of America | Oct 2, 2026 | Oct 12, 2026 | Not stated |
| Instruments Support Engineer | London, United Kingdom | Oct 2, 2026 | Oct 12, 2026 | Not stated |
| Director, Enterprise Applications – SAP Platform | Austin, Texas, United States of America | Oct 1, 2026 | Oct 12, 2026 | Not stated |
| Sr HR Generalist (Northern Europe) | Amsterdam, Netherlands | Sep 30, 2026 | Oct 12, 2026 | Not stated |
| Field Application Engineer (d/f/m) | Paris, France | Sep 29, 2026 | Oct 12, 2026 | Not stated |
| Senior HRBP | Sunnyvale, California, United States of America | Sep 29, 2026 | Oct 12, 2026 | Not stated |
| Senior People Partner | Lodi, California, United States of America | Sep 29, 2026 | Oct 12, 2026 | Not stated |
| Finance BP Manager | Shanghai, China | Sep 28, 2026 | Oct 12, 2026 | Not stated |
| Regulatory Affairs Principal | Sunnyvale, California, United States of America | Sep 28, 2026 | Oct 12, 2026 | Not stated |
| Senior Patent Agent - REMOTE | Austin, Texas, United States of America | Sep 25, 2026 | Oct 12, 2026 | Not stated |
| Director, Innovation DBSL | Bangalore, Karnātaka, India | Sep 24, 2026 | Oct 12, 2026 | Not stated |
| Sr HR Generalist (Southern Europe) | Amsterdam, Netherlands | Sep 23, 2026 | Oct 12, 2026 | Not stated |
| Lead Automation Engineering Technician | Lodi, California, United States of America | Sep 21, 2026 | Oct 12, 2026 | Not stated |
| Director, Product Innovation Management | Sunnyvale, California, United States of America | Sep 18, 2026 | Oct 12, 2026 | Not stated |
| Senior Automation Controls Engineer | Newark, California, United States of America | Sep 16, 2026 | Oct 12, 2026 | Not stated |
| Sr. Manager, Operational Technology Programs & Operations Excellence | Newark, California, United States of America | Sep 15, 2026 | Oct 12, 2026 | Not stated |
| Senior Planner | Shanghai, China | Sep 11, 2026 | Oct 12, 2026 | Not stated |
| Architect, Electrical & Electronics | Bangalore, Karnātaka, India | Sep 8, 2026 | Oct 12, 2026 | Not stated |
| VP & General Manager – Diagnostics Platform, India | Mumbai, Mahārāshtra, India | Sep 7, 2026 | Oct 12, 2026 | Not stated |
| EHS Engineer | Lodi, California, United States of America | Sep 5, 2026 | Oct 12, 2026 | Not stated |
| Clinical Solutions Manager | Alcobendas, Madrid, Spain | Sep 1, 2026 | Oct 12, 2026 | Not stated |
| Manager, Field Action Process | Sunnyvale, California, United States of America | Aug 31, 2026 | Oct 12, 2026 | Not stated |
| Senior Architect — AI Enablement | Bangalore, Karnātaka, India | Aug 20, 2026 | Oct 12, 2026 | Not stated |
| Territory Sales Executive, Orlando, FL | Orlando, Florida, United States of America | Aug 11, 2026 | Oct 12, 2026 | Not stated |
| Lead MFG Automation Engineer | Lodi, California, United States of America | Aug 4, 2026 | Oct 12, 2026 | Not stated |
| Regional Commercial Head, (Healthcare, Diagnostics) | Centurion, Gauteng, South Africa | Aug 4, 2026 | Oct 12, 2026 | Not stated |
| Senior Financial Analyst | Lodi, California, United States of America | Jul 15, 2026 | Oct 12, 2026 | Not stated |
| Staff Demand And Supply Planning Analyst | Sunnyvale, California, United States of America | May 26, 2026 | Oct 12, 2026 | Not stated |
Connect
See your connections at Cepheid on LinkedIn (search by name, results not checked)